Navkar Formulation Pvt Ltd
About Navkar Formulation Pvt Ltd
Data last updated:
Navkar Formulation Pvt Ltd is a private limited company based in Ahmedabad, Gujarat, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 19 April 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1995PTC025513.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.02 Lakh. It is led by directors Jayesh Bhogilal Shah (Managing Director) and Harsha Jayeshbhai Shah.
Its last annual general meeting (AGM) was held on 27 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 114 Medicine Marketnr Paldi Bus Stop Paldi, Ahmedabad, Gujarat, India – 380006.
As per the financials filed for FY 2019, the company reported a revenue of ₹16.64 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹52,902 (net margin 3.2%) and EBITDA of ₹71,483 (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address114 Medicine Marketnr Paldi Bus Stop Paldi, Ahmedabad, Gujarat, India – 380006
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Navkar Formulation Pvt Ltd
FY 2019 filings availableNavkar Formulation Pvt Ltd reported revenue of ₹16.64 Lakh (up 1% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over three years, including 1% growth in the latest year. EBITDA rose 742% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2014-15 to FY 2017-18in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹71,483 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹52,902 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2018-19 | FY 2014-15 to FY 2017-18in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 4.3% | |
| Net Profit Margin | 3.2% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2014-15 to FY 2017-18, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Navkar Formulation are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Navkar Formulation Pvt Ltd
Navkar Formulation has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayesh Bhogilal Shah | Managing Director | 19 Apr 1995 | 31 Years 6 Months | Current |
| Harsha Jayeshbhai Shah | Director | 19 Apr 1995 | 31 Years 6 Months | Current |
Peer Comparison
Navkar Formulation Pvt Ltd is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ritz Pharmaceutical and Foods Products Private Limited | ₹16.68 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Uttar Prdesh, Uttar Pradesh, India |
| Virgo Welltrade Private Limited | ₹16.66 Lakh (FY 2024) | •••• | •••• | -37.0% | •••• | Ahmedabad, Gujarat, India |
| Malola Biologicals Private Limited | ₹16.64 Lakh (FY 2018) | •••• | •••• | 84.0% | •••• | Chennai, Tamil Nadu, India |
| Amaresha Pharmaceuticals Private Limited | ₹16.64 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Chennai, Tamil Nadu, India |
| Agrawal Medicaments Private Limited | ₹16.64 Lakh (FY 2024) | •••• | •••• | -28.0% | •••• | Margao, Goa, India |
| Navkar Formulation Pvt Ltd this company | ₹16.64 Lakh (FY 2019) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Apex Wellness Medipharma Private Limited | ₹16.61 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Relax Health Care Private Limited | ₹16.6 Lakh (FY 2025) | •••• | •••• | 52.0% | •••• | Pratapgarh, Uttar Pradesh, India |
| Chembricks Laboratories Private Limited | ₹16.58 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Napsko Healthcare Private Limited | ₹16.56 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Wisteria Pharma Private Limited | ₹16.55 Lakh (FY 2022) | •••• | •••• | 721.0% | •••• | Bangalore, Karnataka, India |
Peers are the companies nearest to Navkar Formulation by revenue, above and below it, in the Healthcare industry (Ayurvedic Products and Services, Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings
Navkar Formulation Pvt Ltd does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases
Navkar Formulation Pvt Ltd has 1 court case on record: 1 filed by Navkar Formulation. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed by the company against an individual | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Navkar Formulation.
: available in the company report
Recent Activity
Navkar Formulation Pvt Ltd has 2 board changes on record since 1995: 2 appointments. The latest: Harsha Jayeshbhai Shah was appointed as Director on 19 Apr 1995.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Navkar Formulation is an active private limited company based in Ahmedabad, Gujarat, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 19 April 1995 (31+ years old) and is registered under CIN U24231GJ1995PTC025513.
Navkar Formulation has 2 current directors:
- Jayesh Bhogilal Shah - Managing Director
- Harsha Jayeshbhai Shah - Director
The latest financial statements of Navkar Formulation on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 27 September 2019. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Navkar Formulation is U24231GJ1995PTC025513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navkar Formulation has 1 court case on record: 1 filed by the company.
Navkar Formulation was incorporated on 19 April 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Navkar Formulation by revenue are Ritz Pharmaceutical and Foods Products Private Limited, Virgo Welltrade Private Limited, Malola Biologicals Private Limited, Amaresha Pharmaceuticals Private Limited, Agrawal Medicaments Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services, Formulations, Pharma Retail and Distribution).
Harsha Jayeshbhai Shah was appointed as Director on 19 Apr 1995. Jayesh Bhogilal Shah was appointed as Managing Director on 19 Apr 1995.
The registered office of Navkar Formulation is at 114 Medicine Marketnr Paldi Bus Stop Paldi, Ahmedabad, Gujarat, India – 380006.
Navkar Formulation operates in the healthcare industry, in the ayurvedic products and services segment.
The compliance status of Navkar Formulation is active non-compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.